A new HCV core antigen assay based on disassociation of immune complexes: An alternative to molecular biology in the diagnosis of early HCV infection

Transfusion

Volumn 43, Issue 7, 2003, Pages 958-962

  Laperche, Syria ^a   Le Marrec, Nadine ^b   Simon, Nicole ^b   Bouchardeau, Françoise ^b   Defer, Christine ^b   Maniez Montreuil, Michèle ^b   Levayer, Thierry ^b   Zappitelli, Jean Pierre ^b   Lefrère, Jean Jacques ^b  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOCAPSID PROTEIN; VIRUS ANTIGEN;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; CLINICAL ARTICLE; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MOLECULAR BIOLOGY; SENSITIVITY ANALYSIS; SEROCONVERSION; VIRUS CORE; VIRUS DETECTION; VIRUS INFECTION;

ANTIGEN-ANTIBODY COMPLEX; BLOOD DONORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNOASSAY; RENAL DIALYSIS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRAL CORE PROTEINS;

EID: 0038307145     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2003.00430.x     Document Type: Article

References (19)

1. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-4.
2. Busch MP, Korelitz JJ, Kleinman SH, et al. Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiol Donor Study. Transfusion 1995;35:903-10.
3. Courouce AM, Pillonel J. Transfusion-transmitted viral infections. Retrovirus and Viral Hepatitis Working Groups of the French Society of Blood Transfusion. N Engl J Med 1996;335:1609-10.
4. Barrera JM, Francis B, Ercilla G, et al. Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA. Vox Sang 1995;68:15-8.
5. Kolk DP, Dockter J, Linnen J, et al. Significant closure of the human immunodeficiency virus type 1 and hepatitis C virus preseroconversion detection windows with a transcription-mediated-amplification-driven assay. J Clin Microbiol 2002;40:1761-6.
6. Simmonds P, Kurtz J, Tedder R. The UK blood transfusion service: over a (patent) barrel. Lancet 2002;359:1713-14.
7. Courouce AM, Le Marrec N, Bouchardeau F, et al. Efficacy of HCV core antigen detection during the preseroconversion period. Transfusion 2000;40:1198-202.
8. Peterson J, Green G, Iida K, et al. Detection of hepatitis C core antigen in the antibody negative "window" phase of hepatitis C infection. Vox Sang 2000;78:80-5.
9. Tanaka E, Ohue C, Aoyagi K, et al. Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA. Hepatology 2000;32:388-93.
10. Bouvier-Alias M, Patel K, Dahari H, et al. Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication. Hepatology 2002;36:211-8.
11. Durand F, Beauplet A, Marcellin P. Evidence of hepatitis C virus viremia without detectable antibody to hepatitis C virus in a blood donor. Ann Intern Med 2000;133:74-5.
12. Sanz C, Tassies D, Costa J, Freire C, Pereira A. The first case of HCV infection detected before seroconversion in blood donors tested by HCV core antigen ELISA. Transfusion 2002;42:505-6.
13. Muerhoff AS, Jiang L, Shah DO, et al. Detection of HCV core antigen in human serum and plasma with an automated chemiluminescent immunoassay. Transfusion 2002;42:349-56.
14. Busch M. Closing the windows on viral transmission by blood transfusion. In: Stramer SL, editor. Blood safety in the new millennium. Bethesda: American Association of Blood Banks; 2001.
15. Lelie PN, van Drimmelen HA, Cuypers HT, et al. Blood screening assays. Transfusion 2002;42:527-36.
16. Kawai S, Yokosuka O, Kanda T, et al. Quantification of hepatitis C virus by TaqMan PCR: comparison with HCV Amplicor Monitor assay. J Med Virol 1999;58:121-6.
17. Ratge D, Scheiblhuber B, Landt O, Berg J, Knabbe C. Two-round rapid-cycle RT-PCR in single closed capillaries increases the sensitivity of HCV RNA detection and avoids amplicon carry-over. J Clin Virol 2002;24:161-72.
18. Lefrere JJ. Sécurité virale et transplantation d'organes. Virologie 1998;2:227-32.
19. Toyoda H, Sakamoto H, Mizuno T, Horiguchi Y, Nakano H. Eradication of hepatitis C virus 1b by interferon in a health care worker with acute hepatitis following needlestick transmission from a patient with chronic hepatitis C unresponsive to interferon. Scand J Gastroenterol 2000;35:1117-20.